FI833717A0 - Foerfarande foer framstaellning av modifierade, virusbetingade diarrevirusar - Google Patents

Foerfarande foer framstaellning av modifierade, virusbetingade diarrevirusar

Info

Publication number
FI833717A0
FI833717A0 FI833717A FI833717A FI833717A0 FI 833717 A0 FI833717 A0 FI 833717A0 FI 833717 A FI833717 A FI 833717A FI 833717 A FI833717 A FI 833717A FI 833717 A0 FI833717 A0 FI 833717A0
Authority
FI
Finland
Prior art keywords
virus
bvd
diarrevirusar
betingade
modification
Prior art date
Application number
FI833717A
Other languages
English (en)
Other versions
FI82264C (fi
FI833717A (fi
FI82264B (fi
Inventor
Jean-Claude Delgoffe
Michele Lobmann
Nathan Zygraich
Original Assignee
Smith Kline Rit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline Rit filed Critical Smith Kline Rit
Publication of FI833717A0 publication Critical patent/FI833717A0/fi
Publication of FI833717A publication Critical patent/FI833717A/fi
Application granted granted Critical
Publication of FI82264B publication Critical patent/FI82264B/fi
Publication of FI82264C publication Critical patent/FI82264C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation
    • C12N2770/24363—Methods of inactivation or attenuation by chemical treatment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/813—Viral vaccine for bovine species, e.g. cattle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI833717A 1982-10-13 1983-10-12 Framstaellningen av noetets modifierade diarrevirusstammar. FI82264C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/434,155 US4618493A (en) 1982-10-13 1982-10-13 Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them
US43415582 1982-10-13

Publications (4)

Publication Number Publication Date
FI833717A0 true FI833717A0 (fi) 1983-10-12
FI833717A FI833717A (fi) 1984-04-14
FI82264B FI82264B (fi) 1990-10-31
FI82264C FI82264C (fi) 1991-02-11

Family

ID=23723042

Family Applications (1)

Application Number Title Priority Date Filing Date
FI833717A FI82264C (fi) 1982-10-13 1983-10-12 Framstaellningen av noetets modifierade diarrevirusstammar.

Country Status (16)

Country Link
US (1) US4618493A (fi)
EP (1) EP0106831B1 (fi)
JP (3) JPS5989631A (fi)
AT (1) ATE48948T1 (fi)
AU (1) AU572050B2 (fi)
CA (1) CA1216234A (fi)
DE (1) DE3381005D1 (fi)
DK (1) DK170061B1 (fi)
ES (2) ES526380A0 (fi)
FI (1) FI82264C (fi)
GR (1) GR78966B (fi)
IE (1) IE56438B1 (fi)
NO (1) NO166953C (fi)
NZ (1) NZ205491A (fi)
PT (1) PT77454B (fi)
ZA (1) ZA837573B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052606A (en) * 1958-08-30 1962-09-04 Behringwerke Ag Viral mutation with nitrites
US3293129A (en) * 1962-02-01 1966-12-20 Cornell Res Foundation Inc Immunization of cattle against virus diarrhea virus
US3629413A (en) * 1970-02-04 1971-12-21 Univ Southern Illinois Polyvalent bovine vaccines and methods of making and using same
US3907986A (en) * 1972-12-18 1975-09-23 Rit Rech Ind Therapeut Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
GB1390467A (en) * 1973-03-30 1975-04-16 Rit Rech Ind Therapeut Vaccination method using temperature sensitive virus mutants
US3927208A (en) * 1973-05-14 1975-12-16 Rit Rech Ind Therapeut Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
US3962424A (en) * 1974-01-31 1976-06-08 Recherche Et Industrie Therapeutiques (R.I.T.) Live brovine adenovirus vaccines, preparation thereof and method of vaccination using them
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines
JPS5817084B2 (ja) * 1978-08-25 1983-04-05 新明和工業株式会社 塵芥押込処理装置の操作装置

Also Published As

Publication number Publication date
JPH05192139A (ja) 1993-08-03
NZ205491A (en) 1989-07-27
EP0106831A2 (fr) 1984-04-25
EP0106831B1 (fr) 1989-12-27
DK170061B1 (da) 1995-05-15
PT77454B (en) 1986-02-26
ES8504929A1 (es) 1985-04-16
ES526380A0 (es) 1985-04-16
JPH0463862B2 (fi) 1992-10-13
NO166953C (no) 1991-09-18
AU572050B2 (en) 1988-04-28
DK472083A (da) 1984-04-14
NO833717L (no) 1984-04-16
JPH0773494B2 (ja) 1995-08-09
IE832400L (en) 1984-04-13
FI82264C (fi) 1991-02-11
IE56438B1 (en) 1991-07-31
US4618493A (en) 1986-10-21
PT77454A (en) 1983-11-01
GR78966B (fi) 1984-10-02
FI833717A (fi) 1984-04-14
AU1852983A (en) 1984-04-19
JPH0773493B2 (ja) 1995-08-09
JPH05176764A (ja) 1993-07-20
JPS5989631A (ja) 1984-05-23
FI82264B (fi) 1990-10-31
CA1216234A (en) 1987-01-06
ATE48948T1 (de) 1990-01-15
EP0106831A3 (en) 1986-01-22
ES8600058A1 (es) 1985-10-01
DK472083D0 (da) 1983-10-13
ES526382A0 (es) 1985-10-01
DE3381005D1 (de) 1990-02-01
ZA837573B (en) 1984-08-29
NO166953B (no) 1991-06-10

Similar Documents

Publication Publication Date Title
FI103122B1 (fi) Menetelmä muutetun pneumolysiinin valmistamiseksi
ATE20309T1 (de) Pharmazeutische zubereitung.
HK51597A (en) Vaccines for human respiratory virus
US3927208A (en) Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
GB1413614A (en) Virus production
FI833717A (fi) Foerfarande foer framstaellning av modifierade, virusbetingade diarrevirusar
DE69633233D1 (de) Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus
KR840001515B1 (ko) 백신의 제조방법
RU92006181A (ru) Аттенуированный холодоадаптированный штамм вируса гриппа в/ссср/60/69 для получения живой интраназальной гриппозной вакцины
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
Felfe et al. Trends in production of foot-and-mouth disease vaccine.
Ristau et al. Bovine leucosis virus challenge infection of calves following application of BL-3 cells
Wasinski et al. Effect of antibiotics on the immune response of pigs against erysipelas suum vaccinated against swine fever, erysipelas and colibacillosis.
Fribourg-Blanc et al. Congenital Syphilis
Krugman Live attenuated measles vaccine: Its development and characteristics.
Limsuwan et al. Role of the natural immunity to diphtheria in preventing an outbreak of the disease in the community
GB871838A (en) Purification of poliomyelitis virus
GB1131931A (en) Improvements in and relating to vaccines

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SMITHKLINE BECKMAN - ANIMAL HEALTH